Valuation: Tetratherix Limited

Market Cap 339M 236M 210M 196M 178M 336M 22.72B 2.37B 922M 11.6B 886M 867M 37.27B P/E 2027 *
-40.4x
P/E 2028 * -49.3x
Enterprise Value 322M 224M 200M 186M 170M 319M 21.6B 2.25B 876M 11.02B 842M 824M 35.43B EV / Sales 2027 *
36.6x
EV / Sales 2028 * 15.5x
Free-Float
34.23%
Yield 2027 *
-
Yield 2028 * -
1 day+4.23%
1 week+12.33%
Current month+5.56%
1 month-6.67%
3 months+13.10%
6 months+55.37%
Current year+102.74%
1 week 6.1
Extreme 6.1
6.71
1 month 5.82
Extreme 5.82
7.47
Current year 3.09
Extreme 3.09
8.08
1 year 3.09
Extreme 3.09
8.08
3 years 2.88
Extreme 2.88
8.08
5 years 2.88
Extreme 2.88
8.08
10 years 2.88
Extreme 2.88
8.08
Manager TitleAgeSince
Chief Operating Officer - 2015-08-31
Chief Executive Officer - 2021-08-31
Chief Tech/Sci/R&D Officer - 2021-08-31
Director TitleAgeSince
Director/Board Member - 2015-07-31
Chairman - 2024-12-31
Director/Board Member - 2021-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.23%+12.33%+62.20% - 238M
+4.16%+3.42%+49.37%+94.17% 74.16B
-0.37%-3.81%+19.75%+78.12% 57.39B
+1.63%-1.61%+3.83%+36.89% 47.64B
+0.50%+2.94%+344.62%+722.17% 44.29B
+3.05%-1.80%+28.78%+34.51% 42.5B
+1.00%-1.46%+5.17%+111.90% 40.71B
-0.54%+2.41%+9.31%+58.85% 30.97B
+3.88%+7.57%+37.02%+31.69% 28.53B
+0.76%-1.45%-7.44%-11.12% 24.34B
Average +1.83%+0.58%+55.26%+128.58% 39.08B
Weighted average by Cap. +1.72%-0.40%+58.48%+137.48%

Financials

2027 *2028 *
Net sales 8.8M 6.13M 5.47M 5.1M 4.64M 8.74M 591M 61.59M 23.96M 301M 23.02M 22.53M 969M 20.85M 14.53M 12.96M 12.08M 10.99M 20.69M 1.4B 146M 56.77M 714M 54.54M 53.37M 2.3B
Net income -9.66M -6.73M -6.01M -5.6M -5.09M -9.59M -649M -67.63M -26.31M -331M -25.28M -24.74M -1.06B -5.6M -3.91M -3.48M -3.25M -2.95M -5.56M -376M -39.22M -15.26M -192M -14.66M -14.34M -617M
Net Debt -16.72M -11.65M -10.4M -9.69M -8.82M -16.6M -1.12B -117M -45.54M -573M -43.75M -42.81M -1.84B -15.79M -11.01M -9.82M -9.15M -8.32M -15.68M -1.06B -111M -43M -541M -41.32M -40.42M -1.74B
Logo Tetratherix Limited
Tetratherix Limited is an Australia-based company, which has developed a bio stealth fluid matrix that evolves regenerative medicine. The Company's biomaterial platform is built with polymer programming akin to Medical Lego to form implantable products to solve a range of clinical problems. The material is an injectable fluid to avoid causing damage to the body during its application. Upon injection, triggered by physiological temperature, a 3D matrix is formed that physically integrates and adheres to the target tissue. Tegenix and TegenEOS products are developed as a carrier designed to be mixed with a broad array of bone graft materials (BGMs) for dental, oral and orthopedic applications. TetraDerm products can be used in any surgical incision site to reduce scarring. Tutelix products are intended for use as a spacer to reduce side effects from radiation therapy in prostate cancer. It has established its manufacturing center in Sydney, featuring a cleanroom production facility.
Employees
25
Date Price Change Volume
26-10-05 A$6.650 +4.23% 7,961
26-10-05 A$6.380 -1.09% 13,929
26-10-02 A$6.450 +1.10% 4,039
26-10-01 A$6.380 +1.27% 9,528
26-09-30 A$6.300 +6.42% 11,754
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
6.380AUD
Average target price
6.953AUD
Spread / Average Target
+8.98%

Annual profits - Rate of surprise